Detalhe da pesquisa
1.
A paired comparison between glioblastoma "stem cells" and differentiated cells.
Int J Cancer
; 138(7): 1709-18, 2016 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26519239
2.
RIST: a potent new combination therapy for glioblastoma.
Int J Cancer
; 136(4): E173-87, 2015 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25123598
3.
Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide's antiproliferative effect.
J Neurooncol
; 122(1): 21-33, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25524815
4.
Killing me softly--future challenges in apoptosis research.
Int J Mol Sci
; 15(3): 3746-67, 2014 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24595238
5.
What Animal Cancers teach us about Human Biology.
Theranostics
; 11(14): 6682-6702, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34093847
6.
Inhibition of PI3K signalling increases the efficiency of radiotherapy in glioblastoma cells.
Int J Oncol
; 53(5): 1881-1896, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30132519
7.
Blocking distinct interactions between Glioblastoma cells and their tissue microenvironment: A novel multi-targeted therapeutic approach.
Sci Rep
; 8(1): 5527, 2018 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29615749
8.
The effects of PI3K-mediated signalling on glioblastoma cell behaviour.
Oncogenesis
; 6(11): 398, 2017 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29184057
9.
Immune phenotypes predict survival in patients with glioblastoma multiforme.
J Hematol Oncol
; 9(1): 77, 2016 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27585656
10.
Cell Death Induction in Cancer Therapy - Past, Present, and Future.
Crit Rev Oncog
; 21(3-4): 253-267, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27915975
11.
A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy.
PLoS One
; 10(6): e0131670, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26121251
12.
A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy.
Mol Cell Ther
; 2: 32, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-26056598
13.
Artesunate enhances the antiproliferative effect of temozolomide on U87MG and A172 glioblastoma cell lines.
Anticancer Agents Med Chem
; 14(2): 313-8, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24506460
14.
Sequential dosing in chemosensitization: targeting the PI3K/Akt/mTOR pathway in neuroblastoma.
PLoS One
; 8(12): e83128, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24391739
15.
Combined inhibition of HER1/EGFR and RAC1 results in a synergistic antiproliferative effect on established and primary cultured human glioblastoma cells.
Mol Cancer Ther
; 12(9): 1783-95, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23832120
16.
Inhibition of NF-κB signaling ablates the invasive phenotype of glioblastoma.
Mol Cancer Res
; 11(12): 1611-23, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24145173
17.
Bortezomib primes glioblastoma, including glioblastoma stem cells, for TRAIL by increasing tBid stability and mitochondrial apoptosis.
Clin Cancer Res
; 17(12): 4019-30, 2011 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21525171